Early studies in non-Hodgkin lymphoma showed that suppressive B cells expressed membrane-bound TGFβ that promoted the expression of Foxp3 and the development of Tregs, suggesting that Bregs could be pro-tumorigenic in cancer [73, 85]. The gene discussed is TGFB1; the disease is cancer.